Concepedia

Publication | Closed Access

Inhibition of Angiogenesis In Vivo by Interleukin 12

DOI

727

Citations

0

References

1995

Year

Emile E. Voest, B. M. Kenyon, M. OʼReilly, Gary A. Truitt, Robert J. D’Amato, Judah Folkman
JNCI Journal of the National Cancer Institute

Abstract

Recognition of the mechanisms of the antiangiogenic properties of IL 12 may be crucial in planning its clinical applications, including a possibility of coadministration with other inhibitors of neovascularization.